BANK OF AMERICA CORP /DE/ - FINCH THERAPEUTICS GROUP INC ownership

FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 48 filers reported holding FINCH THERAPEUTICS GROUP INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of FINCH THERAPEUTICS GROUP INC
ValueSharesWeighting
Q1 2023$22
-99.4%
56
-99.3%
0.00%
Q4 2022$3,870
-72.4%
8,063
-2.1%
0.00%
Q3 2022$14,000
-22.2%
8,236
+27.9%
0.00%
Q2 2022$18,000
-33.3%
6,441
+17.4%
0.00%
Q1 2022$27,000
-81.1%
5,486
-61.8%
0.00%
Q4 2021$143,000
+308.6%
14,378
+440.7%
0.00%
Q3 2021$35,000
+16.7%
2,659
+26.1%
0.00%
Q2 2021$30,000
-99.7%
2,108
-99.7%
0.00%
-100.0%
Q1 2021$11,615,000719,1950.00%
Other shareholders
FINCH THERAPEUTICS GROUP INC shareholders Q2 2022
NameSharesValueWeighting ↓
Avenir Management Company, LLC 1,663,366$653,7033.23%
Bleichroeder LP 810,416$318,4930.07%
Ikarian Capital, LLC 237,553$93,3590.02%
LAKE STREET ADVISORS GROUP, LLC 739,136$2910.02%
Baupost Group 2,019,008$7930.01%
Proficio Capital Partners LLC 110,559$43,4500.01%
MSD Partners, L.P. 153,397$60,2850.01%
Ballentine Partners, LLC 143,603$56,4360.00%
SVB WEALTH LLC 253,054$99,4500.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 18,783$7,3820.00%
View complete list of FINCH THERAPEUTICS GROUP INC shareholders